We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Plavix Deal Triggers More Antitrust Charges

Law360 (April 20, 2006, 12:00 AM EDT) -- Marking the latest swipe in the epic battle over blockbuster blood thinner Plavix, Apotex Corp., Bristol-Myers Squibb Co. and French pharmaceutical giant Sanofi-Aventis have been hit with antitrust charges by a New York drug cooperative, just weeks after similar charges were filed by a supermarket operator in the same court.

The suit, filed by Rochester Drug Co-Operative Inc. this week in the U.S. District Court for the Southern District of Ohio, charges the trio with engaging in anticompetitive practices by devising a settlement designed to keep...
To view the full article, register now.